Published in Am J Cardiol on August 01, 1994
Service provision and use of anticoagulants in atrial fibrillation. BMJ (1995) 4.81
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
A survey of atrial fibrillation in general practice: the West Birmingham Atrial Fibrillation Project. Br J Gen Pract (1997) 3.29
Fish intake and risk of incident atrial fibrillation. Circulation (2004) 2.82
Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study. Heart (2001) 2.78
A new method for detection and quantification of heartbeat parameters in Drosophila, zebrafish, and embryonic mouse hearts. Biotechniques (2009) 2.30
Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity. Eur J Epidemiol (2010) 2.13
Evaluation of computerized decision support for oral anticoagulation management based in primary care. Br J Gen Pract (1996) 1.83
Status of the epidemiology of atrial fibrillation. Med Clin North Am (2008) 1.80
An epidemiological study on the prevalence of atrial fibrillation in the Chinese population of mainland China. J Epidemiol (2008) 1.68
Clinical relevance of silent atrial fibrillation: prevalence, prognosis, quality of life, and management. J Interv Card Electrophysiol (2000) 1.65
Omega-3 fatty acid supplementation reduces one-year risk of atrial fibrillation in patients hospitalized with myocardial infarction. Eur J Clin Pharmacol (2008) 1.61
Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC). Am Heart J (2010) 1.55
Prevalence and Risk Factors of Atrial Fibrillation in Chinese Elderly: Results from the Chinese Longitudinal Healthy Longevity Survey. Chin Med J (Engl) (2015) 1.51
Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace (2010) 1.50
Independent contribution of diabetes to increased prevalence and incidence of atrial fibrillation. Diabetes Care (2009) 1.49
Prevalence of and risk factors for atrial fibrillation in Korean adults older than 40 years. J Korean Med Sci (2005) 1.47
Reduced prevalence of atrial fibrillation in black patients compared with white patients attending an urban hospital: an electrocardiographic study. J Natl Med Assoc (2002) 1.40
Current perceptions of the epidemiology of atrial fibrillation. Cardiol Clin (2009) 1.38
The burden of cardiovascular disease in the elderly: morbidity, mortality, and costs. Clin Geriatr Med (2009) 1.32
Prevalence of atrial fibrillation and its predictors in nondialysis patients with chronic kidney disease. Clin J Am Soc Nephrol (2009) 1.27
Metabolic stress, reactive oxygen species, and arrhythmia. J Mol Cell Cardiol (2011) 1.26
Defects in ankyrin-based membrane protein targeting pathways underlie atrial fibrillation. Circulation (2011) 1.18
Trends in catheter ablation for atrial fibrillation in the United States. J Hosp Med (2009) 1.17
Treating the right patient at the right time: an innovative approach to the management of atrial fibrillation. Can J Cardiol (2008) 1.16
Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol (2010) 1.13
The sensitivity of the method used to detect atrial fibrillation in population studies affects group-specific prevalence estimates: ethnic and regional distribution of atrial fibrillation in the REGARDS study. J Epidemiol (2009) 1.11
Incidence and severity of coronary artery disease in patients with atrial fibrillation undergoing first-time coronary angiography. PLoS One (2011) 1.10
The new Medicare Part D prescription drug benefit: an estimation of its effect on prescription drug costs in a Medicare population with atrial fibrillation. J Am Geriatr Soc (2007) 1.07
Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update. Open Heart (2014) 1.06
Atrial fibrillation--the growing epidemic. Heart (2007) 1.05
Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation. J Am Heart Assoc (2015) 0.99
Comorbidity associated with atrial fibrillation: a general practice-based study. Br J Gen Pract (2001) 0.98
Epidemiology of arrhythmias and conduction disorders in older adults. Clin Geriatr Med (2012) 0.96
Association of the metabolic syndrome with atrial fibrillation among United States adults (from the REasons for Geographic and Racial Differences in Stroke [REGARDS] Study). Am J Cardiol (2011) 0.96
The burden of atrial fibrillation in the Netherlands. Neth Heart J (2011) 0.94
Screening for atrial fibrillation with baseline and intermittent ECG recording in an out-of-hospital population. BMC Cardiovasc Disord (2013) 0.94
The QT interval and risk of incident atrial fibrillation. Heart Rhythm (2013) 0.93
Impaired kidney function and atrial fibrillation in elderly subjects. J Card Fail (2009) 0.92
The changing epidemiology and natural history of nonvalvular atrial fibrillation: clinical implications. Trans Am Clin Climatol Assoc (2004) 0.91
Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program. Neth Heart J (2010) 0.91
Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications. J Interv Card Electrophysiol (2009) 0.90
Atrial fibrillation in the elderly. J Geriatr Cardiol (2012) 0.90
Atrial fibrillation detection by heart rate variability in Poincare plot. Biomed Eng Online (2009) 0.90
Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review. Cardiol Res Pract (2013) 0.90
Is warfarin really underused in patients with atrial fibrillation? J Gen Intern Med (2001) 0.89
The impact of age on the epidemiology of atrial fibrillation hospitalizations. Am J Med (2013) 0.89
Long-term success and follow-up after atrial fibrillation ablation. Curr Cardiol Rev (2012) 0.88
Cellular and Molecular Mechanisms of Arrhythmia by Oxidative Stress. Cardiol Res Pract (2016) 0.85
Basic transthoracic echocardiography. BMJ (2005) 0.85
Estimating the prevalence of atrial fibrillation in a general population using validated electronic health data. Clin Epidemiol (2013) 0.85
The Utility of Ambulatory Electrocardiographic Monitoring for Detecting Silent Arrhythmias and Clarifying Symptom Mechanism in an Urban Elderly Population with Heart Failure and Hypertension: Clinical Implications. J Atr Fibrillation (2010) 0.85
Methods for the development and assessment of atrial fibrillation and heart failure dog models. J Geriatr Cardiol (2011) 0.84
[New antiarrhythmic drugs for therapy of atrial fibrillation: II. Non-ion channel blockers]. Herzschrittmacherther Elektrophysiol (2006) 0.83
Clinical epidemiology of atrial fibrillation and related cerebrovascular events in the United States. Neurologist (2008) 0.83
Clinical strategies for selecting oral anticoagulants in patients with atrial fibrillation. J Thromb Thrombolysis (2013) 0.83
Atrial fibrillation and heart failure in the elderly. Heart Fail Rev (2012) 0.83
Primary care management for optimized antithrombotic treatment [PICANT]: study protocol for a cluster-randomized controlled trial. Implement Sci (2012) 0.83
Efficacy of Combination Therapy of Statin and Vitamin C in Comparison with Statin in the Prevention of Post-CABG Atrial Fibrillation. Adv Pharm Bull (2013) 0.82
Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study. Br J Gen Pract (2011) 0.82
Warfarin slows deterioration of renal function in elderly patients with chronic kidney disease and atrial fibrillation. Clin Interv Aging (2013) 0.81
Significance and control of cardiac arrhythmias in patients with congestive cardiac failure. Heart Fail Rev (2002) 0.81
Catheter ablation of atrial fibrillation in the elderly. J Geriatr Cardiol (2014) 0.81
Long-term sinus rhythm maintenance after cardioversion of persistent atrial fibrillation: is the treatment's success predictable? Heart Vessels (2006) 0.80
Prevention of heart failure in the elderly: when, where and how to begin? Heart Fail Rev (2012) 0.79
Detection of paroxysmal atrial fibrillation or flutter in patients with acute ischemic stroke or transient ischemic attack by Holter monitoring. Indian Heart J (2014) 0.79
Opportunistic detection of atrial fibrillation in subjects aged 65 years or older in primare care: a randomised clinical trial of efficacy. DOFA-AP study protocol. BMC Fam Pract (2012) 0.79
Relationship of the total atrial conduction time to subclinical atherosclerosis, inflammation and echocardiographic parameters in patients with type 2 diabetes mellitus. Clinics (Sao Paulo) (2015) 0.78
Stroke and bleeding risk in atrial fibrillation. Korean Circ J (2014) 0.78
C-Reactive Protein Gene Polymorphisms and the Risk of Atrial Fibrillation in a Chinese Population in Taiwan. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.78
Acute safety outcomes in younger and older patients with atrial fibrillation treated with catheter ablation. J Interv Card Electrophysiol (2012) 0.78
Number of P-wave fragmentations on P-SAECG correlates with infiltrated atrial fat. Ann Noninvasive Electrocardiol (2013) 0.78
Meta-analysis of the therapeutic effects of various methods for the treatment of chronic atrial fibrillation. Exp Ther Med (2013) 0.78
[Molecular biology of the heart atrium. New insights into the pathophysiology of atrial fibrillation as well as its clinical implications]. Z Kardiol (2004) 0.78
[Atrial fibrillation and thromboprophylaxis in elderly patients]. Z Kardiol (2005) 0.78
High prevalence of modifiable stroke risk factors identified in a pharmacy-based screening programme. Open Heart (2016) 0.77
Atrial fibrillation anticoagulation care in a large urban family medicine practice. Can Fam Physician (2014) 0.77
Individual and Combined Risk Factors for Incident Atrial Fibrillation and Incident Stroke: An Analysis of 3 Million At-Risk US Patients. J Am Heart Assoc (2015) 0.77
Dysfunction of the β2-spectrin-based pathway in human heart failure. Am J Physiol Heart Circ Physiol (2016) 0.77
Electrocardiographic abnormalities in centenarians: impact on survival. BMC Geriatr (2012) 0.77
Patterns of warfarin use in subgroups of patients with atrial fibrillation: a cross-sectional analysis of 430 general practices in the United Kingdom. PLoS One (2013) 0.77
Risk and outcome after ablation of isthmus-dependent atrial flutter in elderly patients. PLoS One (2015) 0.77
Atrial fibrillation in a multiethnic inpatient population of a large public hospital. J Natl Med Assoc (2004) 0.76
Ability of Reduced Lung Function to Predict Development of Atrial Fibrillation in Persons Aged 45 to 84 Years (from the Multi-Ethnic Study of Atherosclerosis-Lung Study). Am J Cardiol (2015) 0.76
Atrial fibrillation: a review of recent studies with a focus on those from the duke clinical research institute. Scientifica (Cairo) (2014) 0.76
Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol (2015) 0.76
How to use implantable loop recorders in clinical trials and hybrid therapy. J Interv Card Electrophysiol (2011) 0.76
Synchronised cardioversion for chronic atrail fibrillation. Ghana Med J (2008) 0.75
Falls and Atrial Fibrillation in Elderly Patients. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2013) 0.75
Sinus Rhythm in Rheumatic Mitral Stenosis after Balloon Mitral Valvotomy: Is it Feasible? J Clin Diagn Res (2017) 0.75
Anticoagulation for the prevention of stroke in non-valvular AF in general practice: room for improvement. Drugs Context (2016) 0.75
Nut consumption and risk of atrial fibrillation in the Physicians' Health Study. Nutr J (2012) 0.75
Atrial Fibrillation: The Science behind Its Defiance. Aging Dis (2016) 0.75
The Optimal Treatment For Atrial Fibrillation In Less Developed Countries. J Atr Fibrillation (2014) 0.75
Effects of pharmacologic therapy on health-related quality of life in elderly patients with atrial fibrillation: a systematic review of randomized and nonrandomized trials. Clin Med Insights Cardiol (2013) 0.75
Mechanisms underlying the development of atrial arrhythmias in heart failure. Heart Fail Rev (2002) 0.75
Medication management of atrial fibrillation: emerging therapies for rhythm control and stroke prevention. P T (2011) 0.75
The Cardiovascular Health Study: design and rationale. Ann Epidemiol (1991) 27.24
Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med (1999) 16.30
Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol (1995) 10.26
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation (1995) 9.13
Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics (1998) 8.48
Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study. JAMA (1998) 8.21
Incidence of and risk factors for atrial fibrillation in older adults. Circulation (1997) 8.18
Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke (1996) 7.81
Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study. Ann Epidemiol (1993) 7.49
Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol (1997) 7.45
Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol (1995) 7.28
Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation (1995) 6.55
Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. JAMA (1997) 5.91
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Predictors of congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol (2000) 5.59
Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomised controlled trials. Lancet (2000) 5.42
The messenger under attack -- intimidation of researchers by special-interest groups. N Engl J Med (1997) 5.14
Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. N Engl J Med (2000) 4.84
Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation (1993) 4.75
Rationale and design for the Antihypertensive and Lipid Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Research Group. Am J Hypertens (1996) 4.66
Community-level comparisons between the grocery store environment and individual dietary practices. Prev Med (1991) 4.45
Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group. Stroke (1991) 4.21
Racial differences in serum cotinine levels among smokers in the Coronary Artery Risk Development in (Young) Adults study. Am J Public Health (1990) 3.82
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Diabetes in older adults: comparison of 1997 American Diabetes Association classification of diabetes mellitus with 1985 WHO classification. Lancet (1998) 3.61
Are drugs within a class interchangeable? Lancet (1999) 3.58
Echocardiographic measurements in normal subjects from infancy to old age. Circulation (1980) 3.55
JNC VI: timing is everything. Lancet (1997) 3.48
Ankle-arm index as a predictor of cardiovascular disease and mortality in the Cardiovascular Health Study. The Cardiovascular Health Study Group. Arterioscler Thromb Vasc Biol (1999) 3.36
Cardiovascular risk factors in young adults. The CARDIA baseline monograph. Control Clin Trials (1991) 3.30
Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old. Lancet (1996) 3.28
Time to act on drug safety. JAMA (1998) 3.22
Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke (1992) 3.09
A method for using MR to evaluate the effects of cardiovascular disease on the brain: the cardiovascular health study. AJNR Am J Neuroradiol (1994) 3.07
Reductase inhibitor monotherapy and stroke prevention. Arch Intern Med (1997) 3.05
Diuretic therapy for hypertension and the risk of primary cardiac arrest. N Engl J Med (1994) 3.04
The association of antihypertensive agents with MRI white matter findings and with Modified Mini-Mental State Examination in older adults. J Am Geriatr Soc (1997) 2.98
Serum potassium level and dietary potassium intake as risk factors for stroke. Neurology (2002) 2.98
Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation (2000) 2.96
Importance of heart failure with preserved systolic function in patients > or = 65 years of age. CHS Research Group. Cardiovascular Health Study. Am J Cardiol (2001) 2.93
American Heart Association Prevention Conference. IV. Prevention and Rehabilitation of Stroke. Risk factors. Stroke (1997) 2.87
Arterial wall thickness is associated with prevalent cardiovascular disease in middle-aged adults. The Atherosclerosis Risk in Communities (ARIC) Study. Stroke (1995) 2.86
British guidelines on managing hypertension. Provide evidence, progress, and an occasional missed opportunity. BMJ (1999) 2.83
M-mode echocardiographic predictors of six- to seven-year incidence of coronary heart disease, stroke, congestive heart failure, and mortality in an elderly cohort (the Cardiovascular Health Study). Am J Cardiol (2001) 2.81
Sleep disturbance, psychosocial correlates, and cardiovascular disease in 5201 older adults: the Cardiovascular Health Study. J Am Geriatr Soc (1997) 2.79
The effects of drug treatment for hypertension on morbidity and mortality from cardiovascular disease: a review of randomized controlled trials. Prog Cardiovasc Dis (1987) 2.77
Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study. Arch Neurol (1998) 2.77
Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol (1997) 2.76
Subclinical disease as an independent risk factor for cardiovascular disease. Circulation (1995) 2.71
Depressive symptoms and risks of coronary heart disease and mortality in elderly Americans. Cardiovascular Health Study Collaborative Research Group. Circulation (2000) 2.71
Assessment and control for confounding by indication in observational studies. J Am Geriatr Soc (1999) 2.71
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina). J Am Coll Cardiol (1999) 2.58
Magnetic resonance abnormalities and cardiovascular disease in older adults. The Cardiovascular Health Study. Stroke (1994) 2.57
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med (2006) 2.55
Natural statins and stroke risk. Circulation (1999) 2.55
Thickening of the carotid wall. A marker for atherosclerosis in the elderly? Cardiovascular Health Study Collaborative Research Group. Stroke (1996) 2.48
Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation (1998) 2.47
Cigarette smoking behavior is strongly related to educational status: the CARDIA study. Prev Med (1990) 2.47
The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA (1999) 2.42
Frequency and predictors of stroke death in 5,888 participants in the Cardiovascular Health Study. Neurology (2001) 2.41
Inflammation and hemostasis biomarkers and cardiovascular risk in the elderly: the Cardiovascular Health Study. J Thromb Haemost (2007) 2.40
Apolipoproteins versus lipids as indices of coronary risk and as targets for statin treatment. Lancet (2003) 2.37
Differences in sociodemographic, health status, and lifestyle characteristics among American Indians by telephone coverage. Prev Med (1994) 2.37
Relationship of cardiovascular risk factors to echocardiographic left ventricular mass in healthy young black and white adult men and women. The CARDIA study. Coronary Artery Risk Development in Young Adults. Circulation (1995) 2.36
Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study. J Am Soc Echocardiogr (1992) 2.31
Potential problems with random zero sphygmomanometer. Lancet (1990) 2.31
Electrocardiographic findings in a healthy biracial population. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Am J Cardiol (1998) 2.31
Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. BMJ (1989) 2.27
The association between cholesterol and death from injury. Ann Intern Med (1994) 2.26
Family history as a risk factor for primary cardiac arrest. Circulation (1998) 2.25
Antihypertensive drug therapies and the risk of ischemic stroke. Arch Intern Med (2001) 2.24
Prevalence and correlates of snoring and observed apneas in 5,201 older adults. Sleep (1996) 2.23
Therapeutic benefits of ACE inhibitors and other antihypertensive drugs in patients with type 2 diabetes. Diabetes Care (2000) 2.22
Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. JAMA (1992) 2.21
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA (1999) 2.21
Treatment of hypertensive patients with diabetes. Lancet (1998) 2.16
Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women. Blood (1997) 2.15
Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study. Arterioscler Thromb Vasc Biol (1999) 2.15
Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial. Stroke (1996) 2.10